Nouveauté
Patents, Profits, And Superbugs
Par :Formats :
Disponible dans votre compte client Decitre ou Furet du Nord dès validation de votre commande. Le format ePub est :
- Compatible avec une lecture sur My Vivlio (smartphone, tablette, ordinateur)
- Compatible avec une lecture sur liseuses Vivlio
- Pour les liseuses autres que Vivlio, vous devez utiliser le logiciel Adobe Digital Edition. Non compatible avec la lecture sur les liseuses Kindle, Remarkable et Sony
, qui est-ce ?Notre partenaire de plateforme de lecture numérique où vous retrouverez l'ensemble de vos ebooks gratuitement
Pour en savoir plus sur nos ebooks, consultez notre aide en ligne ici
C'est si simple ! Lisez votre ebook avec l'app Vivlio sur votre tablette, mobile ou ordinateur :
- FormatePub
- ISBN8233158629
- EAN9798233158629
- Date de parution13/07/2026
- Protection num.pas de protection
- Infos supplémentairesepub
- ÉditeurLinda Balsamo
Résumé
Antibiotics transformed modern medicine. But what happens when they stop working?Antimicrobial resistance (AMR) is one of the greatest threats to global health, already claiming millions of lives each year and putting routine surgeries, cancer treatment, organ transplantation, and modern healthcare at risk. Yet while bacteria continue to evolve, the development of new antibiotics has slowed dramatically.
Why?In Patents, Profits, and Superbugs, Dr. Umeshkumar KU explores the hidden forces driving one of the most urgent public health crises of our time. Going beyond microbiology, this book examines how patent systems, pharmaceutical business models, economic incentives, public policy, agriculture, and global governance have shaped the fight against antimicrobial resistance-and why the current system often rewards profits over lifesaving innovation.
Combining insights from biotechnology, intellectual property law, One Health, and innovation policy, the book explains complex issues in a clear and engaging style. Through real patient stories, historical perspectives, scientific evidence, and policy analysis, it reveals why antibiotic innovation has stalled, how patent strategies influence access to medicines, and what governments, researchers, industry, and society can do to build a more sustainable future.
Rather than blaming a single industry or institution, Patents, Profits, and Superbugs offers a balanced, evidence-based examination of the structural challenges that have allowed antimicrobial resistance to become a global crisis-and presents practical ideas for reform. Whether you are a healthcare professional, researcher, policymaker, patent professional, student, or simply someone concerned about the future of medicine, this book provides an accessible and thought-provoking exploration of one of humanity's defining scientific and policy challenges.
The microbes are evolving. The question is whether our systems can evolve fast enough.
Why?In Patents, Profits, and Superbugs, Dr. Umeshkumar KU explores the hidden forces driving one of the most urgent public health crises of our time. Going beyond microbiology, this book examines how patent systems, pharmaceutical business models, economic incentives, public policy, agriculture, and global governance have shaped the fight against antimicrobial resistance-and why the current system often rewards profits over lifesaving innovation.
Combining insights from biotechnology, intellectual property law, One Health, and innovation policy, the book explains complex issues in a clear and engaging style. Through real patient stories, historical perspectives, scientific evidence, and policy analysis, it reveals why antibiotic innovation has stalled, how patent strategies influence access to medicines, and what governments, researchers, industry, and society can do to build a more sustainable future.
Rather than blaming a single industry or institution, Patents, Profits, and Superbugs offers a balanced, evidence-based examination of the structural challenges that have allowed antimicrobial resistance to become a global crisis-and presents practical ideas for reform. Whether you are a healthcare professional, researcher, policymaker, patent professional, student, or simply someone concerned about the future of medicine, this book provides an accessible and thought-provoking exploration of one of humanity's defining scientific and policy challenges.
The microbes are evolving. The question is whether our systems can evolve fast enough.
